cytarabine has been researched along with curcumin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blijlevens, NM; de Witte, TJ; Donnelly, JP; M'Rabet, L; Marteijn, J; Timal, S; van't Land, B | 1 |
| Biswas, J; Biswas, R; Mukherjee, A; Mukherjee, S; Roy, M; Sarkar, R | 1 |
| Desai, U; Jain, N; Mirza, S; Rawal, R; Shah, K | 1 |
| Chiou, SS; Lin, PC; Shieh, TM; Shih, YH; Tseng, YH; Yang, RC | 1 |
| Chen, Q; Chen, X; Liu, J; Luo, W; Sun, H; Zhou, G | 1 |
5 other study(ies) available for cytarabine and curcumin
| Article | Year |
|---|---|
Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Cell Line; Curcumin; Cytarabine; Drug Interactions; Female; Intestinal Mucosa; Methotrexate; NF-kappa B; Phenylethyl Alcohol; Rats; Rats, Inbred Strains | 2004 |
Curcumin augments the efficacy of antitumor drugs used in leukemia by modulation of heat shock proteins via HDAC6.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Biomarkers, Tumor; Cell Cycle Checkpoints; Curcumin; Cytarabine; DNA-Binding Proteins; Gene Expression Regulation, Leukemic; Heat Shock Transcription Factors; Heat-Shock Proteins; Histone Deacetylase 6; Histone Deacetylases; HL-60 Cells; Humans; Imatinib Mesylate; K562 Cells; Oxidative Stress; Piperazines; Pyrimidines; Transcription Factors | 2014 |
Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Cytarabine; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Neoplasm Proteins; Real-Time Polymerase Chain Reaction; Structure-Activity Relationship; Vault Ribonucleoprotein Particles | 2016 |
Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells.
Topics: Adolescent; Apoptosis; Cell Line, Tumor; Child; Curcumin; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Indoles; Ketoglutaric Acids; Leukemia, Myeloid, Acute; Male; Purines; Signal Transduction; TOR Serine-Threonine Kinases; Transaminases | 2021 |
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cholesterol; Curcumin; Cytarabine; Drug Resistance, Neoplasm; Drug Synergism; Gastrointestinal Microbiome; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Metabolomics; Metagenomics; Mice; Xenograft Model Antitumor Assays | 2022 |